Faron Pharmaceuticals Feed

Land	Finland
Lista	First North Finland
Sektor	Hälsovård
Industri	Bioteknik

2023-09-22 17:00:00 Faron Pharmaceuticals Announces Board Changes -1,97% | 0,03 MEUR

2023-09-22 17:00:00 Faron Pharmaceuticals Oy: Board Changes -1,97% | 0,03 MEUR

2023-09-22 12:33:01 Faron Pharmaceuticals Ltd Results of the Extraordinary General Meeting -0,26% | 0,07 MEUR

2023-09-22 12:00:00 Faron Pharmaceuticals Oy: Results of EGM -0,26% | 0,07 MEUR

2023-09-21 08:00:00 Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer -1,92% | 0,16 MEUR

2023-09-21 08:00:00 Faron Pharmaceuticals Oy: Faron Appoints Interim Chief Medical Officer -1,92% | 0,16 MEUR

2023-09-08 08:00:00 Faron Pharmaceuticals Oy: Change in the Board of Directors -2,33% | 0,14 MEUR

2023-09-06 08:00:00 Faron Pharmaceuticals Ltd. to Present at the H.C. Wainwright 25th Annual Global Investment Conference +0,63% | 0,11 MEUR

2023-09-06 08:00:00 Faron Pharmaceuticals Oy: Faron Pharmaceuticals Ltd. to Present at the H.C. Wainwright 25th Annual Global Investment Conference +0,63% | 0,11 MEUR

2023-09-01 11:00:00 Faron Pharmaceuticals Oy: NOTICE OF FARON PHARMACEUTICALS LTD'S EXTRAORDINARY GENERAL MEETING +8,14% | 0,16 MEUR

2023-08-31 15:00:00 Faron Pharmaceuticals Oy: Exercise of options, Directors Dealing, Issue of equity -1,60% | 0,09 MEUR

2023-08-29 08:01:00 Faron Pharmaceuticals Oy: Faron 2023 Half-Year Financial Results -2,81% | 0,18 MEUR

2023-08-29 08:00:00 Faron Pharmaceuticals Oy: FDA Orphan Drug Designation for Bexmarilimab -2,81% | 0,18 MEUR

2023-08-29 06:01:00 Faron Reports Half-Year Financial Results, January 1 – June 30, 2023 -2,81% | 0,18 MEUR

2023-08-29 06:00:00 Faron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid Leukemia -2,81% | 0,18 MEUR

2023-08-04 14:00:00 Faron Pharmaceuticals Notice of Half-Year Financial Results +5,41% | 0,09 MEUR

2023-08-04 08:00:00 Faron Pharmaceuticals Oy: Notice of Half-Year Financial Results +5,41% | 0,09 MEUR

2023-08-02 14:00:00 Faron to Participate in Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference +2,50% | 0,06 MEUR

2023-08-02 08:00:00 Faron Pharmaceuticals Oy: Faron to Participate at Canaccord Conference +2,50% | 0,06 MEUR

2023-07-25 08:00:00 Faron Pharmaceuticals Oy: Grant of options +1,54% | 0,06 MEUR

2023-07-19 10:54:38 Faron to Hold Conference Call to Discuss New Positive Clinical Data from Phase I/II BEXMAB Study of Bexmarilimab in Relapsed/Refractory AML and MDS +11,89% | 0,37 MEUR

2023-07-19 09:00:00 Faron Updates Positive Clinical Data from Phase I/II BEXMAB Study of Bexmarilimab in Relapsed/Refractory AML and MDS BEXMAB Study Update +11,89% | 0,37 MEUR

2023-07-19 08:01:00 Faron Pharmaceuticals Oy: Faron to Hold BEXMAB Study Conference Call +11,89% | 0,37 MEUR

2023-07-19 08:00:00 Faron Pharmaceuticals Oy: BEXMAB study Update +11,89% | 0,37 MEUR

2023-06-30 17:45:00 Faron Pharmaceuticals Oy: Holding(s) in Company +1,01% | 0,06 MEUR

2023-06-29 08:00:00 Faron Pharmaceuticals Oy: Announcement of Placing +0,52% | 6,72 MEUR

2023-06-12 08:00:00 Faron Pharmaceuticals Oy: Exercise of options +1,99% | 0,07 MEUR

2023-06-09 09:00:00 Faron Pharmaceuticals Oy: New biomarker data from BEXMAB study at EHA2023 +1,86% | 0,06 MEUR

2023-06-05 08:00:00 Faron Pharmaceuticals Oy: Board Member to Assume Transactional Advisor Role +0,32% | 0,01 MEUR

2023-04-24 08:00:00 Faron Pharmaceuticals Oy: Bexmarilimab Efficacy and Safety in MATINS Trial +0,54% | 0,07 MEUR

2023-04-19 08:00:00 Faron Pharmaceuticals Oy: Bexmarilimab KOL Event -2,14% | 0,11 MEUR

2023-04-18 08:00:00 Faron Pharmaceuticals Oy: Poster Presentations at AACR 2023 -2,86% | 0,28 MEUR

2023-04-17 08:00:00 Faron Pharmaceuticals Oy: BEXMAB study update +12,74% | 0,30 MEUR

2023-04-13 17:30:00 Faron Pharmaceuticals Oy: Faron at Canaccord Oncology Virtual Conference -1,87% | 0,02 MEUR

2023-03-29 08:00:00 Faron Pharmaceuticals Oy: Appointment of Chief Financial Officer -1,39% | 0,02 MEUR

2023-03-24 14:35:00 Faron Pharmaceuticals Oy: Board Change -3,51% | 0,08 MEUR

2023-03-24 14:30:00 Faron Pharmaceuticals Oy: Results of AGM -3,51% | 0,08 MEUR

2023-03-22 08:00:00 Faron Pharmaceuticals Oy: Positive FDA Feedback to Progress Bexmarilimab +2,39% | 0,05 MEUR

2023-03-03 10:00:00 Faron Pharmaceuticals Oy: Notice of Faron Pharmaceuticals Ltd's AGM -1,84% | 0,06 MEUR

2023-03-03 08:15:00 Faron Pharmaceuticals Oy: Faron's Annual Report 2022 Published -1,84% | 0,06 MEUR

2023-03-03 08:00:00 Faron Pharmaceuticals Oy: Financial Statement January 1 to December 31 2022 -1,84% | 0,06 MEUR

2023-02-06 19:00:00 Faron Pharmaceuticals Oy: Update to Faron's Financial Calendar for 2023 +0,44% | 0,02 MEUR

2023-02-06 08:00:00 Faron Pharmaceuticals Oy: Notice of 2022 Full-Year Results and Annual Report -1,15% | 0,03 MEUR

2023-02-01 16:45:00 Faron Pharmaceuticals Oy: Holding(s) in Company +2,77% | 0,05 MEUR

2023-01-27 18:45:00 Faron Pharmaceuticals Oy: Holding(s) in Company -0,15% | 0,12 MEUR

2023-01-27 08:00:00 Faron Pharmaceuticals Oy: Results of Placing -8,87% | 12,6 MEUR

2023-01-26 17:30:00 Faron Pharmaceuticals Oy: Proposed Issue and Placing -8,87% | 12,6 MEUR

2023-01-16 08:00:00 Faron Pharmaceuticals Oy: BEXMAB study update +13,35% | 0,35 MEUR

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2023-08-29	Kvartalsrapport 2023-Q2
2023-03-27	Ordinarie utdelning FARON 0.00 EUR
2023-03-24	Årsstämma 2023
2023-03-03	Bokslutskommuniké 2022
2022-08-25	Kvartalsrapport 2022-Q2
2022-07-07	Extra Bolagsstämma 2022
2022-04-25	Ordinarie utdelning FARON 0.00 EUR
2022-04-22	Årsstämma 2022
2022-03-25	Bokslutskommuniké 2021
2021-08-26	Kvartalsrapport 2021-Q2
2021-04-26	Ordinarie utdelning FARON 0.00 EUR
2021-04-23	Årsstämma 2021
2021-03-25	Bokslutskommuniké 2020
2020-05-14	Ordinarie utdelning FARON 0.00 EUR
2020-05-13	Årsstämma 2020
2020-03-20	Bokslutskommuniké 2019

Faron Pharmaceuticals

Kalender

Beskrivning

Faron Pharmaceuticals

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden